Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

INTUITIVE SURGICAL INC Director's Dealing 2023

Feb 15, 2023

29809_dirs_2023-02-14_f60f0d5d-5e47-427f-88e0-eb8a9736cdf0.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: INTUITIVE SURGICAL INC (ISRG)
CIK: 0001035267
Period of Report: 2023-02-13

Reporting Person: MOHR MARSHALL (Executive VP Global Business S)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2023-02-13 Common Stock M 54000 $63.2456 Acquired 54000 Direct
2023-02-13 Common Stock S 33249 $245.6127 Disposed 20751 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2023-02-13 Non-Qualified Stock Option (right to buy) $63.2456 M 54000 Disposed 2023-02-15 Common Stock (54000) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 100353 Indirect

Footnotes

F1: The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on September 8, 2023.

F2: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $245.10 to $246.47 as follows: 29,736 shares sold at $245.10 to $246.10; and 3,513 shares sold at $246.15 to $246.47. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

F3: Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. Option shall vest 1/8 six months after the date of grant and 1/48th each month thereafter.